The double-edged sword of evolution
Open Access
- 3 July 2017
- journal article
- editorial
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Abstract
African trypanosomiasis is a disease caused by trypanosome parasites that affects humans and other animals in sub-Saharan Africa. In humans, the disease manifests itself as sleeping sickness, and it can be fatal if untreated. Previous research has shown that a protein called APOL1 (short for Apolipoprotein 1) protects against many different species of trypanosome parasites in humans (Vanhamme et al., 2003). However, two subspecies have evolved independent mechanisms to become resistant to APOL1: Trypanosoma brucei rhodesiense, which predominates in East Africa, and Trypanosoma brucei gambiense, which is more common in West Africa (Uzureau et al., 2013; Pays et al., 2014).Keywords
This publication has 9 references indexed in Scilit:
- APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasiseLife, 2017
- Unravelling Human Trypanotolerance: IL8 is Associated with Infection Control whereas IL10 and TNFα Are Associated with Subsequent Disease DevelopmentPLOS Pathogens, 2014
- The molecular arms race between African trypanosomes and humansNature Reviews Microbiology, 2014
- Evolution of the primate trypanolytic factor APOL1Proceedings of the National Academy of Sciences, 2014
- Mechanism of Trypanosoma brucei gambiense resistance to human serumNature, 2013
- Human host determinants influencing the outcome of Trypanosoma brucei gambiense infectionsParasite Immunology, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Apolipoprotein L-I is the trypanosome lytic factor of human serumNature, 2003